10-122082837-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_206862.4(TACC2):c.337T>A(p.Phe113Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000756 in 1,613,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_206862.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TACC2 | NM_206862.4 | c.337T>A | p.Phe113Ile | missense_variant | 4/23 | ENST00000369005.6 | NP_996744.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TACC2 | ENST00000369005.6 | c.337T>A | p.Phe113Ile | missense_variant | 4/23 | 1 | NM_206862.4 | ENSP00000358001 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151984Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000108 AC: 27AN: 250980Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135696
GnomAD4 exome AF: 0.0000766 AC: 112AN: 1461426Hom.: 0 Cov.: 31 AF XY: 0.0000798 AC XY: 58AN XY: 727032
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151984Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74218
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2022 | The c.337T>A (p.F113I) alteration is located in exon 4 (coding exon 3) of the TACC2 gene. This alteration results from a T to A substitution at nucleotide position 337, causing the phenylalanine (F) at amino acid position 113 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at